Vasohibins encode tubulin detyrosinating activity

  • Science. 2017 Dec 15;358(6369):1453-1456. doi: 10.1126/science.aao5676.
Joppe Nieuwenhuis  1 Athanassios Adamopoulos  1 Onno B Bleijerveld  1 Abdelghani Mazouzi  1 Elmer Stickel  1 Patrick Celie  1 Maarten Altelaar  1  2 Puck Knipscheer  3  4 Anastassis Perrakis  1 Vincent A Blomen  5 Thijn R Brummelkamp  5  4  6
Affiliations
  • 1. Division of Biochemistry, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands.
  • 2. Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 CH Utrecht, Netherlands.
  • 3. Hubrecht Institute-KNAW, University Medical Center Utrecht, 3584 CT Utrecht, Netherlands.
  • 4. CGC.nl, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands.
  • 5. Division of Biochemistry, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands. [email protected] [email protected].
  • 6. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
Abstract

Tubulin is subjected to a number of posttranslational modifications to generate heterogeneous microtubules. The modifications include removal and ligation of the C-terminal tyrosine of ⍺-tubulin. The Enzymes responsible for detyrosination, an activity first observed 40 years ago, have remained elusive. We applied a genetic screen in haploid human cells to find regulators of tubulin detyrosination. We identified SVBP, a peptide that regulates the abundance of vasohibins (VASH1 and VASH2). Vasohibins, but not SVBP alone, increased detyrosination of ⍺-tubulin, and purified vasohibins removed the C-terminal tyrosine of ⍺-tubulin. We found that vasohibins play a cell type-dependent role in detyrosination, although cells also contain an additional detyrosinating activity. Thus, vasohibins, hitherto studied as secreted angiogenesis regulators, constitute a long-sought missing link in the tubulin tyrosination cycle.